Anonymous ID: 02924e April 18, 2020, 11:20 p.m. No.8847938   🗄️.is 🔗kun

Professor Didier Raoult Releases the Results of a New Hydroxychloroquine Treatment Study on 1061 Patients

 

The new study, of which the abstract was released today, was performed at IHU Méditerranée Infection, Marseille, France. A cohort of 1061 COVID-19 patients, treated for at least 3 days with the Hydroxychloroquine-Azithromycin (HCQ-AZ) combination and a follow-up of at least 9 days was investigated. Key findings are: No cardiac toxicity was observed. A good clinical outcome and virological cure was obtained in 973 patients within 10 days (91.7%) A poor outcome was observed for 46 patients (4.3%); 10 were transferred to intensive care units, 5 patients died (0.47%) (74-95 years old) and 31 required 10 days of hospitalization or more. The authors conclude that: The HCQ-AZ combination, when started immediately after diagnosis, is a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagiosity in most cases.”

 

Background In a recent survey, most physicians worldwide considered that hydroxychloroquine (HCQ) and azithromycin (AZ) are the two most effective drugs among available molecules against COVID-19. Nevertheless, to date, one preliminary clinical trial only has demonstrated its efficacy on the viral load. Additionally, a clinical study including 80 patients was published, and in vitro efficiency of this association was demonstrated.

 

Methods The study was performed at IHU Méditerranée Infection, Marseille, France. A cohort of 1061 COVID-19 patients, treated for at least 3 days with the HCQ-AZ combination and a follow-up of at least 9 days was investigated. Endpoints were death, worsening and viral shedding persistence.

 

Findings From March 3rd to April 9th, 2020, 59,655 specimens from 38,617 patients were tested for COVID-19 by PCR. Of the 3,165 positive patients placed in the care of our institute, 1061 previously unpublished patients met our inclusion criteria. Their mean age was 43.6 years old and 492 were male (46.4%). No cardiac toxicity was observed. A good clinical outcome and virological cure was obtained in 973 patients within 10 days (91.7%). Prolonged viral carriage at completion of treatment was observed in 47 patients (4.4%) and was associated to a higher viral load at diagnosis (p < 10-2) but viral culture was negative at day 10 and all but one were PCR-cleared at day 15. A poor outcome was observed for 46 patients (4.3%); 10 were transferred to intensive care units, 5 patients died (0.47%) (74-95 years old) and 31 required 10 days of hospitalization or more. Among this group, 25 patients are now cured and 16 are still hospitalized (98% of patients cured so far). Poor clinical outcome was significantly associated to older age (OR 1.11), initial higher severity (OR 10.05) and low hydroxychloroquine serum concentration. In addition, both poor clinical and virological outcomes were associated to the use of selective beta-blocking agents and angiotensin II receptor blockers (P<0.05). Mortality was significantly lower in patients who had received 3 days of HCQ-AZ than in patients treated with other regimens both at IHU and in all Marseille public hospitals (p< 10-2).

 

Interpretation The HCQ-AZ combination, when started immediately after diagnosis, is a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagiosity in most cases.

 

http://covexit.com/professor-didier-raoult-releases-the-results-of-a-new-hydroxychloroquine-treatment-study-on-1061-patients/

 

https://www.facebook.com/PICphysicians/posts/1598932386929578?tn=-R

 

https://www.mediterranee-infection.com/wp-content/uploads/2020/04/Abstract_Raoult_EarlyTrtCovid19_09042020_vD1v.pdf?fbclid=IwAR2Bx-Fldm2fFsLg7L06BYUz-8QvwuJ-hAW9uWmwx1KdKzCU0YGHtSwXXWw

 

https://www.mediterranee-infection.com/wp-content/uploads/2020/04/Table_final_website_IHU_09_04_2020.pdf

 

Checked Qresear.ch haven't seen this published yet..this Doc, has done and extensive study on Hydrochloroquine, the results are in the images with his findings as well as indications of what other health issues it is beneficial for as well.

Anonymous ID: 02924e April 18, 2020, 11:33 p.m. No.8848034   🗄️.is 🔗kun   >>8050 >>8368 >>8435

'Heartbroken' Obama 'eager' to help Biden defeat Trump in election

 

Former President Barack Obama seems "very eager" to help ex-Vice President Joe Biden defeat President Trump. Obama insiders reportedly expect the former president to campaign for Biden during the remainder of 2020, though he previously did not have confidence in the former vice president's ability to win the election. Sources continued to say that Trump's presidency has left Obama "heartbroken," listing the federal government's response to the coronavirus pandemic as a reason for a change in leadership. “The coronavirus disaster and the [federal] government’s inability to lead on it is searing in his brain … more than anything else Trump has done,” a second insider told the New York Post. “Obama is generally heartbroken by the Donald Trump presidency.”

 

Obama issued his long-anticipated endorsement of Biden for president on Tuesday, several days after the Democrat secured his place as the only remaining candidate for the party's nomination. “Choosing Joe to be my vice president was one of the best decisions I ever made, and he became a close friend. And I believe Joe has all the qualities we need in a president right now,” Obama said in a video. Prior to the endorsement, Trump speculated that Obama may "know something" that prompted him to withhold an earlier endorsement. "I don't know why President Obama hasn't supported Joe Biden a long time ago. There's something he feels is wrong," Trump said during a press briefing at the White House more than a week ago, adding, "He knows something that you don't know, that I think I know. But you don't know."

 

Biden reportedly did not inspire confidence in the former president. “You don’t have to do this, Joe, you really don’t,” Obama told Biden prior to his campaign launch, according to the New York Times. However, with Biden as the presumptive Democratic nominee for president, Obama summoned top Biden aides to his Washington, D.C., office to develop campaign strategy. Obama instructed them that, whether the former vice president were to win or lose the presidential race, they cannot allow Biden to “embarrass himself” or “damage his legacy."

https://www.washingtonexaminer.com/news/heartbroken-obama-eager-to-help-biden-defeat-trump-in-election

Anonymous ID: 02924e April 18, 2020, 11:49 p.m. No.8848138   🗄️.is 🔗kun   >>8204 >>8368 >>8435

Watchdog subpoenas Google for Hillary Clinton emails

 

A conservative watchdog group served a court-authorized subpoena on Google to compel the company to hand over all the emails from a Google account which may contain thousands of Hillary Clinton’s emails. Judicial Watch, a conservative-leaning D.C.-based watchdog group, announced this week that it had served a subpoena against the Silicon Valley tech firm as part of its Freedom of Information Act court battle seeking all of Clinton’s emails from her time as secretary of state, including the tens of thousands that were deleted from her private email server.

 

The group is specifically honing in on a Google email account belonging to Paul Combetta, the Platte River Networks information tech specialist who set and managed Clinton’s email server and used BleachBit to help permanently delete Clinton’s digital records. There is evidence to suggest that Combetta was automatically copying and forwarding emails from Clinton’s private email server to a Google cache on another server. The subpoena from Judicial Watch seeks every Clinton email from her time at the State Department from January 2009 until February 2013, and asked Google to hand the records over by May 13. During a D.C. federal court hearing in August, U.S. District Court Judge Royce Lamberth noted the Google cache “does not appear to have ever been reconstructed and searched” and suggested Judicial Watch “ought to shake this tree.” And in March, Lamberth authorized the Google subpoena. “The subpoena seeks to discover new emails, so it certainly relates to whether [the] State [Department] conducted an adequate search,” Lamberth said. “The Court is not confident that State currently possesses every Clinton email recovered by the FBI; even years after the FBI investigation, the slow trickle of new emails has yet to be explained. For this reason, the Court believes the subpoena would be worthwhile and may even uncover additional previously undisclosed emails. Accordingly, the Court GRANTS this request.”

 

Judicial Watch president Tom Fitton said “a federal court, tired of the State and Justice Departments’ gamesmanship, authorized Judicial Watch’s subpoena to Google to follow a lead on the Clinton emails.” The Washington Examiner has reached out to Google for comment. The subpoena asked for “any and all Clinton emails, including metadata, sent or forwarded to or from or saved, stored, archive, or contained in the Gmail account associated with” CarterHeavyIndustries[at]gmail[dot]com, the email account set up by Combetta. Combetta previously told the FBI he created a "dummy" email account to transfer archived emails into a mailbox entitled "HRC archive" on another server. The existence of that “dummy” email account was revealed in DOJ Inspector General Michael Horowitz’s report on the Clinton email investigation, dubbed Midyear Exam, which he released in June 2018. Cambetta, who used software designed to prevent forensic recovery while deleting Clinton’s emails, “refused to speak” with the DOJ inspector general or Congress.

https://www.washingtonexaminer.com/news/watchdog-subpoenas-google-for-hillary-clinton-emails

Anonymous ID: 02924e April 19, 2020, 12:03 a.m. No.8848195   🗄️.is 🔗kun   >>8368 >>8435

CDC lab contamination reportedly delayed coronavirus test rollout

The Dept. of Health and Human Services is investigating the protocol breakdown

 

Scientists at the Centers for Disease Control and Prevention who were working to roll out a critical coronavirus detection test were delayed in doing so due to a reported contamination in an on-site laboratory, a mistake that is now being investigated by the federal Department of Health and Human Services. The Food and Drug Administration this week said that scientists with the CDC had failed to adhere to containment standards while developing the test, exposing the kits to contamination and setting the rollout of the test back as much as a month. The organization "made its test in one of its laboratories, rather than in its manufacturing facilities," against its own protocol, the FDA said.

 

The revelation comes at a time when politicians and administration critics have accused the federal government of falling seriously behind in the number of tests it should be conducting. The U.S. has performed the highest total number of coronavirus tests in the world, though by population numbers it has lagged behind countries such as Belgium, Spain and Germany. The CDC on Friday acknowledged that its quality control procedures "were not sufficient" when scientists were developing the tests and said that it was ramping up those standards moving forward.

https://justthenews.com/politics-policy/coronavirus/cdc-lab-contamination-reportedly-delayed-coronavirus-test-rollout